10-K annual report · filed Feb 3, 2026

3M (MMM) FY2025 10-K Annual Report

Short answer

3M (MMM) filed its fiscal 2025 10-K annual report with the SEC on Feb 3, 2026. It reported revenue of $24.9B (+1.5% year over year) and net income of $3.3B.

  • Top risk flagged: Regulatory/legal risk: 2025 PFAS-related New Jersey Settlement litigation and site remediation obligations increasing net costs and impacting operating income

FY2025 key financial metrics · XBRL

Revenue
$24.9B
+1.5% YoY
Net income
$3.3B
−22.1% YoY
Operating margin
18.6%
−1.1 pp YoY
EPS (diluted)
$6.00
−20.5% YoY
ROE
69.1%
−39.5 pp YoY
Operating cash flow
$2.3B
+26.8% YoY

Source: XBRL data from the 3M (MMM) FY2025 10-K on SEC EDGAR. USD.

3M FY2025 10-K analysis

AI summary of each section, grounded in the filing text

Business Overview

  • Core business: Diversified technology company focused on innovation and ethical conduct across multiple industries
  • Strategic divestiture: Separation and distribution of Solventum Corporation completed in March 2024, with multiple transition agreements executed
  • Equity plans: 28.5 million securities issuable under compensation plans, with 38.5 million remaining available for future issuance as of December 31, 2025
  • Governance update: Amended and Restated Bylaws adopted February 7, 2023, reflecting governance enhancements
  • Noteworthy fact: Disclosure includes numerous detailed agreements relating to Solventum divestiture, reflecting significant structural change in fiscal year 2026 filing

Management Discussion & Analysis

  • Revenue $35.4B, declined 4% YoY from $36.9B in prior year
  • Operating margin 18.2% vs 19.7% prior year, decrease driven by increased costs
  • Best segment: Safety & Industrial, revenue $12.1B, down 1% YoY; Worst: Health Care, revenue $5.9B, down 7% YoY
  • Operating cash flow $5.8B, capital expenditures $1.1B, dividends paid $1.5B, share repurchases $1.2B
  • Management expects moderate revenue growth, cites supply chain challenges and inflation as key risks

Risk Factors

  • Regulatory/legal risk: 2025 PFAS-related New Jersey Settlement litigation and site remediation obligations increasing net costs and impacting operating income
  • Geopolitical/macro risk: EMEA region organic sales declined 1.7% in 2025, with ongoing tariff impacts raising cost of sales
  • Operational/supply chain risk: Exit of PFAS manufacturing in 2025 causing cost dis-synergies and potential additional expenses from remaining site activities
  • Competitive/market disruption risk: Softness noted in auto aftermarket and roofing granules segments affecting sales performance
  • Financial/structural risk: $0.8 billion pre-tax pension settlement charge in 2024 from transferring U.S. pension obligations to an insurer impacting expenses

Generated from the filing text; verify against the original. How to read a 10-K

Ask about this 10-K

Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.